GlassScriptPhysician profile
Raj Pratap Mathur
NPI 1992864177
$5,211.12
in general payments reported to CMS, 2019-2025
18 companies · $400 in 2025
The $400 reported for 2025 was more than what 75% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $716 · 2020: $417 · 2021: $1,284 · 2022: $837 · 2023: $835 · 2024: $721 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,956.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,384.56 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $575.13 | 2020-2023 | |
| Glaxosmithkline, LLC. | $329.81 | 2019-2023 | Trelegy Ellipta, Arexvy |
| Ironwood Pharmaceuticals, INC | $136.52 | 2019-2022 | |
| Zealand Pharma US, INC. | $125.04 | 2021 | |
| Lilly USA, LLC | $95.15 | 2019-2025 | Zepbound, Mounjaro, Amyvid |
| Novartis Pharmaceuticals Corporation | $92.66 | 2019-2022 | |
| Amgen INC. | $89.91 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $88.67 | 2021 | |
| Janssen Pharmaceuticals, INC | $50.54 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.25 | 2021-2022 | |
| Pfizer INC. | $42.71 | 2019 | |
| Allergan, INC. | $41.16 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.58 | 2022 | |
| Exact Sciences Corporation | $28.07 | 2024 | Cologuard Collection Kit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $24.36 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.29 | 2019 | |
| Gilead Sciences, INC. | $12.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raj Mathur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.